This population was characterized by a Th1 effector memory profile in mice and was also identified in peripheral blood of melanoma patients responding to anti-CTLA-4 antibodies in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) [31]. This evidence concerns the gene CSF2 and melanoma.